down arrow

Ferozsons Laboratories Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PK0005201014
PKR
379.11
-14.05 (-3.57%)

Jun 13

KAR

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
5,091.90
4,730.95
4,528.99
3,811.89
3,744.04
3,870.28
4,428.54
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,091.90
4,730.95
4,528.99
3,811.89
3,744.04
3,870.28
4,428.54
Raw Material Cost
3,025.41
2,645.90
2,680.36
2,358.27
2,077.66
2,405.63
2,709.43
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
109.72
171.49
193.91
220.66
195.76
134.96
121.07
Selling and Distribution Expenses
1,582.13
1,625.00
1,273.69
948.25
1,234.12
1,122.66
1,168.64
Other Expenses
-10.97
-17.15
-19.39
-22.07
-19.58
-13.50
-12.11
Total Expenditure (Excl Depreciation)
4,607.54
4,270.90
3,954.05
3,306.52
3,311.78
3,528.29
3,878.07
Operating Profit (PBDIT) excl Other Income
484.4
460.09999999999997
574.9
505.4
432.29999999999995
342
550.5
Other Income
26.14
38.81
-20.61
-17.26
31.60
-68.58
36.81
Operating Profit (PBDIT)
782.66
713.04
738.88
597.40
599.07
409.02
711.04
Interest
109.72
171.49
193.91
220.66
195.76
134.96
121.07
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,066.49
2,085.06
1,848.63
1,453.62
1,666.38
1,464.64
1,719.11
Depreciation
267.91
214.39
197.97
143.14
135.21
136.00
123.75
Profit Before Tax
405.03
327.16
346.99
233.60
268.11
138.05
466.21
Tax
157.22
149.61
105.97
36.59
102.74
26.42
184.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
199.47
150.45
220.40
183.33
134.83
101.89
263.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
199.47
150.45
220.40
183.33
134.83
101.89
263.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
48.34
27.10
20.63
13.68
30.54
9.74
18.37
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
247.81
177.55
241.02
197.01
165.37
111.63
281.47
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
12,169.53
11,970.07
11,448.70
11,228.31
8,417.93
8,283.10
8,181.21
Earnings per share (EPS)
4.59
3.46
5.07
4.22
3.1
2.34
6.05
Diluted Earnings per share
4.59
3.46
5.07
4.22
3.1
2.34
6.05
Operating Profit Margin (Excl OI)
9.6%
9.72%
12.4%
12.37%
11.55%
8.83%
12.43%
Gross Profit Margin
13.22%
11.45%
12.03%
9.88%
10.77%
7.08%
13.32%
PAT Margin
3.92%
3.18%
4.87%
4.81%
3.6%
2.63%
5.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2025 is 7.63% vs 4.46% in Dec 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2025 is 39.53% vs -26.31% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2025 is 12.21% vs -11.23% in Dec 2024

stock-summary

Interest

QoQ Growth in quarter ended Mar 2025 is -36.03% vs -11.55% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

Compare Quarterly Results Of Ferozsons Laboratories Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(PKR)
Change(%)
Net Sales
5,091.90
8,720.07
-3,628.17
-41.61%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,091.90
8,720.07
-3,628.17
-41.61%
Raw Material Cost
3,025.41
5,781.92
-2,756.51
-47.67%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
109.72
16.68
93.04
557.79%
Selling and Distribution Expenses
1,582.13
1,386.02
196.11
14.15%
Other Expenses
-10.97
-1.67
-9.30
-556.89%
Total Expenditure (Excl Depreciation)
4,607.54
7,167.94
-2,560.40
-35.72%
Operating Profit (PBDIT) excl Other Income
484.36
1,552.13
-1,067.77
-68.79%
Other Income
26.14
-260.53
286.67
110.03%
Operating Profit (PBDIT)
782.66
1,305.10
-522.44
-40.03%
Interest
109.72
16.68
93.04
557.79%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2,066.49
2,938.15
-871.66
-29.67%
Depreciation
267.91
0.00
267.91
Profit Before Tax
405.03
1,288.42
-883.39
-68.56%
Tax
157.22
498.63
-341.41
-68.47%
Provisions and contingencies
0
0
0.00
Profit After Tax
199.47
789.79
-590.32
-74.74%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
199.47
789.79
-590.32
-74.74%
Share in Profit of Associates
0
0
0.00
Minority Interest
48.34
0.00
48.34
Other related items
0.00
0.00
0.00
Consolidated Net Profit
247.81
789.79
-541.98
-68.62%
Equity Capital
0
0
0.00
Face Value
10.00
0.00
0.00
Reserves
12,169.53
7,097.05
5,072.48
71.47%
Earnings per share (EPS)
4.59
81.89
-77.30
-94.39%
Diluted Earnings per share
4.59
81.89
-77.30
-94.39%
Operating Profit Margin (Excl OI)
9.60%
17.95%
0.00
-8.35%
Gross Profit Margin
13.22%
14.78%
0.00
-1.56%
PAT Margin
3.92%
9.06%
0.00
-5.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 509.19 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 7.63% vs 4.46% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 36.00% vs 19.82% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 24.78 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 39.53% vs -26.31% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 49.82% vs 314.54% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 75.65 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 12.21% vs -11.23% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 33.30% vs -3.52% in Mar 2024

Quarterly - Interest
Interest 10.97 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -36.03% vs -11.55% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -43.97% vs 160.37% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.60%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."